ZA200200743B - Preserved pharmaceutical formulations. - Google Patents

Preserved pharmaceutical formulations.

Info

Publication number: ZA200200743B
Authority: ZA; South Africa
Prior art keywords: pharmaceutical formulations; preserved pharmaceutical; preserved; formulations; pharmaceutical
Prior art date: 1999-07-22

Application number

ZA200200743A

Other languages

English (en)

Inventor

Atef Gayed

Original Assignee

Aventis Pharma Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-07-22

Filing date

2002-01-28

Publication date

2003-06-25

2002-01-28 Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc

2003-06-25 Publication of ZA200200743B publication Critical patent/ZA200200743B/xx

Links

239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oil, Petroleum & Natural Gas (AREA)
Engineering & Computer Science (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Dermatology (AREA)
Communicable Diseases (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Oncology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)

ZA200200743A 1999-07-22 2002-01-28 Preserved pharmaceutical formulations. ZA200200743B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US22881599P	1999-07-22	1999-07-22

Publications (1)

Publication Number	Publication Date
ZA200200743B true ZA200200743B (en)	2003-06-25

Family

ID=22858657

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200200743A ZA200200743B (en)	1999-07-22	2002-01-28	Preserved pharmaceutical formulations.

Country Status (21)

Country	Link
US (1)	US7109161B1 (cs)
EP (1)	EP1200128A1 (cs)
JP (1)	JP2003520777A (cs)
KR (2)	KR20020032534A (cs)
CN (1)	CN1371287A (cs)
AU (1)	AU777410C (cs)
BR (1)	BR0012674A (cs)
CA (1)	CA2378892C (cs)
CZ (1)	CZ2002265A3 (cs)
EA (1)	EA007070B1 (cs)
EE (1)	EE200200038A (cs)
HK (1)	HK1050317A1 (cs)
HR (1)	HRP20020160A2 (cs)
HU (1)	HUP0202235A3 (cs)
IL (1)	IL147756A (cs)
NO (1)	NO20020304L (cs)
NZ (1)	NZ516736A (cs)
PL (1)	PL353026A1 (cs)
WO (1)	WO2001007086A1 (cs)
YU (1)	YU4602A (cs)
ZA (1)	ZA200200743B (cs)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2003520777A (ja)	1999-07-22	2003-07-08	アベンティス・ファーマスーティカルズ・インコーポレイテツド	防腐医薬製剤
US20020107469A1 (en) *	2000-11-03	2002-08-08	Charles Bolan	Apheresis methods and devices
WO2003080149A2 (en)	2002-03-20	2003-10-02	Mannkind Corporation	Inhalation apparatus
EP1686976A2 (en) *	2003-11-05	2006-08-09	Santarus, Inc.	Combination of proton pump inhibitor and sleep aid
DE202004020676U1 (de) *	2004-03-10	2005-11-10	Bioceuticals Arzneimittel Ag	Erythropoietin-Flüssigformulierung
US8338648B2 (en)	2004-06-12	2012-12-25	Signum Biosciences, Inc.	Topical compositions and methods for epithelial-related conditions
PL1786784T3 (pl)	2004-08-20	2011-04-29	Mannkind Corp	Kataliza syntezy diketopiperazyn
KR101644250B1 (ko)	2004-08-23	2016-07-29	맨카인드 코포레이션	약물 전달용 디케토피페라진염, 디케토모르포린염 또는 디케토디옥산염
US9028852B2 (en)	2004-09-07	2015-05-12	3M Innovative Properties Company	Cationic antiseptic compositions and methods of use
CN104324362B (zh)	2005-09-14	2018-04-24	曼金德公司	以提高活性试剂对结晶微粒表面的亲和力为基础的药物配制方法
IN2015DN00888A (cs)	2006-02-22	2015-07-10	Mannkind Corp
MX2008013405A (es)	2006-04-18	2009-03-09	Ekr Therapeutics Inc	Composiciones farmaceuticas premezcladas listas para uso.
CA2667682A1 (en)	2006-10-27	2008-05-15	The Curators Of The University Of Missouri	Compositions comprising acid labile proton pump inhibiting agents, at least one other pharmaceutically active agent and methods of using same
US20090069418A1 (en) *	2007-04-25	2009-03-12	Alkayed Nabil J	Compositions and Methods for the Treatment of Disorders Associated with Aberrant Vasodilation
DE102007054794A1 (de) *	2007-11-13	2009-05-14	Agilan Gmbh	Wässrige Eisen-Dextran-Zubereitung mit ein oder mehreren Verbindungen der para-Hydroxy-Benzoesäureester und/oder deren Salzen
BRPI0819976A2 (pt) *	2007-12-03	2019-02-12	Signum Biosciences, Inc.	composto mimético de ácido para a inibição de isoprenil-s-cisteinil metiltransferase, composição compreedendo os mesmos, bem como uso dos ditos compostos.
JP2011512416A (ja)	2008-02-20	2011-04-21	ザ・キュレイターズ・オブ・ザ・ユニバーシティー・オブ・ミズーリ	オメプラゾール及びランソプラゾールの組合せと緩衝剤を含んでなる組成物とそれを使用する方法
US8485180B2 (en)	2008-06-13	2013-07-16	Mannkind Corporation	Dry powder drug delivery system
ES2929343T3 (es)	2008-06-13	2022-11-28	Mannkind Corp	Inhalador de polvo seco accionado por aspiración para la administración de fármacos
KR101628410B1 (ko)	2008-06-20	2016-06-08	맨카인드 코포레이션	흡입 활동에 관한 실시간 프로파일링을 위한 대화형 장치 및 방법
ES2400210T3 (es)	2008-10-02	2013-04-08	Mylan Inc.	Método para preparar un laminado de adhesivo multicapa
US8314106B2 (en)	2008-12-29	2012-11-20	Mannkind Corporation	Substituted diketopiperazine analogs for use as drug delivery agents
TW201138782A (en) *	2010-04-26	2011-11-16	Besins Healthcare Lu Sarl	Low-oil pharmaceutical emulsion compositions comprising progestogen
IL223742A (en)	2010-06-21	2016-06-30	Mannkind Corp	A dry powder inhaler and preparation for it
KR101805087B1 (ko)	2010-09-16	2017-12-05	주식회사 엘지화학	높은 방부력을 제공하는 오일 주사 제형
AU2012236150B2 (en) *	2011-04-01	2016-03-31	Mannkind Corporation	Blister package for pharmaceutical cartridges
WO2012174472A1 (en)	2011-06-17	2012-12-20	Mannkind Corporation	High capacity diketopiperazine microparticles
US20130011494A1 (en) *	2011-07-10	2013-01-10	Mohammad Rahimi	Composition for treating decubitus ulcers in diabetic and non-diabetic patients
CN102993031B (zh)	2011-09-19	2014-03-26	北京桑普生物化学技术有限公司	一种制备芳基多氧烷基季铵类化合物的方法
BR112014009686A2 (pt)	2011-10-24	2018-08-07	Mannkind Corp	composição analgésica inalável, pó seco e método para tratar dor
CN104619369B (zh)	2012-07-12	2018-01-30	曼金德公司	干粉药物输送系统和方法
MX375448B (es)	2013-07-18	2025-03-06	Mannkind Corp	Composiciones farmacéuticas en polvo seco estables al calor y métodos.
US10307464B2 (en)	2014-03-28	2019-06-04	Mannkind Corporation	Use of ultrarapid acting insulin
DE102016000277A1 (de)	2016-01-15	2017-07-20	Beiersdorf Ag	Kosmetische Zubereitungen enthaltend Benzethonium Chlorid und Diole
US11825842B2 (en)	2016-12-16	2023-11-28	Aurorium Holdings Llc	Quaternary amine formulations and uses thereof
US11364225B2 (en) *	2019-08-21	2022-06-21	Bn Intellectual Properties, Inc.	Pharmaceutical formulation for treating symptoms of migraine and cluster headaches, and method of using the same

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3489837A (en) *	1968-07-11	1970-01-13	Leroy J Hyman	Synergistic antiseptic composition consisting of 9-aminoacridine hydrochloride and benzethonium chloride
US4053628A (en)	1971-05-12	1977-10-11	Fisons Limited	Composition
JPS6045849B2 (ja)	1980-08-25	1985-10-12	林原健	ヒトエリトロポエチンの製造方法
US4506018A (en)	1982-12-30	1985-03-19	Becton, Dickinson And Company	Blood diluent
US4703008A (en)	1983-12-13	1987-10-27	Kiren-Amgen, Inc.	DNA sequences encoding erythropoietin
JPS6197229A (ja)	1984-10-18	1986-05-15	Chugai Pharmaceut Co Ltd	安定なエリトロポエチン製剤
JPH0651637B2 (ja)	1985-03-28	1994-07-06	エーザイ株式会社	ペプタイドの吸着防止組成物
US5045529A (en) *	1989-03-27	1991-09-03	Bionostics, Inc.	Tonometric fluid for blood gas and co-oximetry instruments
JP3249147B2 (ja)	1990-06-01	2002-01-21	キリン−アムジエン・インコーポレーテツド	生理活性蛋白含有経口製剤
DE4126983A1 (de)	1991-08-15	1993-02-18	Boehringer Mannheim Gmbh	Verfahren zur herstellung von humanprotein-enthaltenden, konservierten arzneimitteln fuer infusions- oder injektionszwecke
US5661125A (en)	1992-08-06	1997-08-26	Amgen, Inc.	Stable and preserved erythropoietin compositions
ES2079320B1 (es)	1994-05-17	1996-10-16	Cusi Lab	Disolucion oftalmica a base de un diclofenaco y tobramicina y sus aplicaciones.
US5611464A (en)	1995-05-30	1997-03-18	Ciba Geigy Corporation	Container for preserving media in the tip of a solution dispenser
US5997893A (en) *	1998-01-20	1999-12-07	Ethicon, Inc.	Alcohol based anti-microbial compositions with cosmetic appearance
US6022551A (en)	1998-01-20	2000-02-08	Ethicon, Inc.	Antimicrobial composition
JP2003520777A (ja)	1999-07-22	2003-07-08	アベンティス・ファーマスーティカルズ・インコーポレイテツド	防腐医薬製剤
ATE304863T1 (de)	1999-07-22	2005-10-15	Aventis Pharma Inc	Erythropoietin formulierungen des mehrfachdosis- typs

2000
- 2000-07-21 JP JP2001511969A patent/JP2003520777A/ja not_active Abandoned
- 2000-07-21 HK HK03102131.3A patent/HK1050317A1/zh unknown
- 2000-07-21 CZ CZ2002265A patent/CZ2002265A3/cs unknown
- 2000-07-21 HU HU0202235A patent/HUP0202235A3/hu unknown
- 2000-07-21 BR BR0012674-8A patent/BR0012674A/pt not_active IP Right Cessation
- 2000-07-21 KR KR1020027000952A patent/KR20020032534A/ko not_active Ceased
- 2000-07-21 EA EA200200072A patent/EA007070B1/ru not_active IP Right Cessation
- 2000-07-21 WO PCT/US2000/020040 patent/WO2001007086A1/en not_active Ceased
- 2000-07-21 EP EP00948895A patent/EP1200128A1/en not_active Withdrawn
- 2000-07-21 IL IL14775600A patent/IL147756A/xx active IP Right Grant
- 2000-07-21 PL PL00353026A patent/PL353026A1/xx not_active Application Discontinuation
- 2000-07-21 CN CN00812154A patent/CN1371287A/zh active Pending
- 2000-07-21 EE EEP200200038A patent/EE200200038A/xx unknown
- 2000-07-21 CA CA002378892A patent/CA2378892C/en not_active Expired - Lifetime
- 2000-07-21 KR KR1020077025804A patent/KR20070116181A/ko not_active Ceased
- 2000-07-21 HR HR20020160A patent/HRP20020160A2/hr not_active Application Discontinuation
- 2000-07-21 YU YU4602A patent/YU4602A/sh unknown
- 2000-07-21 US US10/031,922 patent/US7109161B1/en not_active Expired - Lifetime
- 2000-07-21 AU AU62325/00A patent/AU777410C/en not_active Expired
- 2000-07-21 NZ NZ516736A patent/NZ516736A/en not_active IP Right Cessation
2002
- 2002-01-21 NO NO20020304A patent/NO20020304L/no not_active Application Discontinuation
- 2002-01-28 ZA ZA200200743A patent/ZA200200743B/xx unknown

Also Published As

Publication number	Publication date
IL147756A (en)	2005-12-18
CA2378892C (en)	2008-07-15
HRP20020160A2 (en)	2003-10-31
CZ2002265A3 (cs)	2002-08-14
HK1050317A1 (zh)	2003-06-20
US7109161B1 (en)	2006-09-19
NO20020304L (no)	2002-03-21
EA200200072A1 (ru)	2003-02-27
CN1371287A (zh)	2002-09-25
EA007070B1 (ru)	2006-06-30
IL147756A0 (en)	2002-08-14
NZ516736A (en)	2004-02-27
AU6232500A (en)	2001-02-13
AU777410C (en)	2006-08-17
PL353026A1 (en)	2003-10-06
KR20070116181A (ko)	2007-12-06
KR20020032534A (ko)	2002-05-03
YU4602A (sh)	2005-06-10
EE200200038A (et)	2003-04-15
NO20020304D0 (no)	2002-01-21
HUP0202235A3 (en)	2004-05-28
EP1200128A1 (en)	2002-05-02
BR0012674A (pt)	2002-09-17
AU777410B2 (en)	2004-10-14
WO2001007086A1 (en)	2001-02-01
JP2003520777A (ja)	2003-07-08
CA2378892A1 (en)	2001-02-01
HUP0202235A2 (hu)	2002-11-28

Publication	Publication Date	Title
ZA200200743B (en)	2003-06-25	Preserved pharmaceutical formulations.
ZA993338B (en)	2000-11-14	Pharmaceutical formulations.
MXPA01010676A (es)	2003-08-20	Composicion farmaceutica de vitamina d o un analogo de vitamina d y al menos un corticoesteroide.
MXPA03007215A (es)	2003-12-04	Formulaciones farmaceuticas.
ZA200110022B (en)	2003-05-28	Thiazoloderivatives and pharmaceutical compositions containing them.
ZA200108304B (en)	2003-03-26	Agrochemical formulations.
ZA200003998B (en)	2000-08-14	Pharmaceutical compositions.
ZA985364B (en)	1999-12-20	Pharmaceutical formulations containing voriconazole.
MXPA01012478A (es)	2003-10-14	Formulaciones farmaceuticas mejoradas.
ZA200101012B (en)	2002-08-06	Pharmaceutical combinations.
ZA200104280B (en)	2002-08-26	Pharmaceutical combination preparations.
ZA200203486B (en)	2003-08-04	Novel pharmaceutical compositions.
ZA200203707B (en)	2003-10-29	Pharmaceutical combinations.
ZA200000857B (en)	2001-05-31	Pharmaceutical composition.
ZA200210359B (en)	2003-11-13	Pharmaceutical compositions.
AU6715600A (en)	2001-03-19	Pharmaceutical formulations
MXPA03002105A (es)	2003-06-19	Composiciones farmaceuticas.
EP1173216A4 (en)	2004-09-29	PHARMACEUTICAL FORMULATIONS
ZA200203311B (en)	2003-12-31	Pharmaceutical carrier formulation.
AU1385801A (en)	2001-04-30	Pharmaceutical formulations
ZA200110454B (en)	2002-12-20	Pharmaceutical complex.
ZA99890B (en)	2000-08-04	Pharmaceutical compositions.
GB9930578D0 (en)	2000-02-16	Pharmaceutical formulations
GB9906126D0 (en)	1999-05-12	Pharmaceutical formulations
ZA994697B (en)	2000-01-31	Pharmaceutical formulation.